Formulation Technician II (Second Shift)
Thermo Fisher ScientificSalary not specified
- Full Time
- Junior (1 to 2 years)
Moderna
(Fixed-Term) Manufacturing Associate, Drug Substance - Shift Position
Not SpecifiedCompensation
Junior (1 to 2 years), Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Biotechnology, ManufacturingIndustries
Requirements
Candidates should possess a Bachelor’s degree in a relevant scientific field, such as Biology, Chemistry, or a related discipline, and demonstrate at least 2 years of experience in a manufacturing environment, preferably within the pharmaceutical or biotechnology industry. Strong knowledge of current Good Manufacturing Practices (cGMP) and health and safety regulations is essential, along with the ability to operate and maintain production equipment and perform routine maintenance tasks.
Responsibilities
As a Manufacturing Associate, you will operate and monitor production equipment while adhering to cGMP, SOPs, and health and safety procedures, maintain a clean and compliant work environment, execute operations and maintain accurate manufacturing documentation, perform routine equipment maintenance, troubleshoot digital and equipment-related issues, keep training records and operational logs up to date, and collaborate closely with QA and other cross-functional teams to meet production KPIs. You will also practice safe work habits, proactively identify and report safety concerns, and participate in multiple projects and continuous improvement initiatives.
Skills
cGMP
SOPs
GMP
Pharmaceutical Manufacturing
Equipment Maintenance
Troubleshooting
Documentation
Safety Regulations
Digital Equipment
Moderna
Develops mRNA-based medicines for health
About Moderna
Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.
Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees